Database for studying obesity and metabolic surgery outcomes in China
Official title: Chinese Obesity and MEtabolic Surgery Database
Run by Jinan University Guangzhou · NCT06275061 · Data updated 2026-11-12
This study is collecting information from people in China who have obesity and are having weight loss surgery to see how well these surgeries work in the long run.
Quick facts
| Study type | Observational |
|---|---|
| Sex | All |
| Enrollment | 1000000 (estimated) |
| Sponsor | Jinan University Guangzhou Academic / other |
| Locations | 1 site (Guangzhou, Guangdong) |
| Status | Recruiting |
| Started | May 1, 2020 |
| Main results expected | December 31, 2030 |
| Study ends | December 31, 2040 |
| Registry record updated | February 23, 2024 |
| Trial ID | NCT06275061 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are patients diagnosed with obesity who are planning to undergo metabolic or bariatric surgery.
✕Probably not a fit
Patients who are being treated for obesity through non-surgical methods will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The Chinese Obesity and MEtabolic Surgery Database (COMES Database) aims to collect and analyze data on the long-term effects of metabolic and bariatric surgery specifically within the Chinese population. This observational study will gather information from patients diagnosed with obesity who are undergoing these surgical procedures. By establishing a national database, the study seeks to provide insights into the effectiveness and outcomes of these surgeries in managing obesity and related metabolic disorders. The data collected will help inform future treatment strategies and improve patient care.
Why it matters
Potential benefit: If successful, this study could lead to improved understanding and management of obesity and metabolic disorders in the Chinese population.
How similar studies have gone: Other studies have shown success in similar approaches, indicating the potential for valuable insights from this database.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients diagnosed as obesity undergoing metabolic and bariatric surgery. Exclusion Criteria: * Patients treated by non-surgical modalities.
Where it's running
-
The First Affiliated Hospital of Jinan University
Guangzhou, Guangdong, China Recruiting
Study contacts
- Study coordinator: Wah Yang, MD
- Email: yangwah@qq.com
- Phone: +8615920373823
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Efsubaglutide alfa for weight loss after metabolic surgery
This trial will test whether efsubaglutide alfa helps people who remain obese six months after metabolic surgery lose weight and improve obesity-related health problems.
-
15-year outcomes after sleeve gastrectomy in France
This study looks at how people who had sleeve gastrectomy have fared over 15 years to see long-term weight changes and health effects.
-
Sarcopenia After Bariatric Surgery: Changes in Muscle and Function
This study tests how bariatric surgery affects muscle mass, strength, and physical performance over time in adults undergoing the procedure.
-
Fasted versus fed aerobic exercise for weight loss and heart health
This 16-week program will see if doing aerobic exercise before breakfast (fasted) versus after eating helps adults with overweight or obesity lose more weight and improve heart-related measures.
-
Flow-controlled versus volume-controlled ventilation during bariatric surgery
This trial will see if flow-controlled ventilation or volume-controlled ventilation gives better oxygen levels and lower airway pressures during bariatric surgery in adults with obesity.
-
Preoperative IV ferric derisomaltose to prevent anemia and improve quality of life in obese patients having bariatric surgery
This trial tests whether a single preoperative IV ferric derisomaltose dose, compared with saline placebo, prevents postoperative anemia and improves quality of life for iron-deficient obese patients undergoing bariatric surgery.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.